NCT00129285View on ClinicalTrials.gov

Modafinil Treatment for Cocaine-Dependent Individuals

PHASE2CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

April 30, 2008

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Low Dose Modafinil

modafinil 200 mg/day

DRUG

High Dose Modafinil

modafinil 400 mg/day

DRUG

Placebo

placebo 400 mg/day

Trial Locations (1)

19104 6178

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pennsylvania

OTHER

NCT00129285 - Modafinil Treatment for Cocaine-Dependent Individuals | Biotech Hunter | Biotech Hunter